Previous Article | Next Article ![]()
Infection and Immunity, August 1999, p. 3793-3799, Vol. 67, No. 8
Department of Microbiology and Infectious
Diseases, University of Calgary, Calgary, Alberta,
Canada,1 and Veterans Administration
Hospital, Alexandria, Louisiana2
Received 15 October 1998/Returned for modification 10 February
1999/Accepted 5 May 1999
Moraxella catarrhalis expresses surface receptor
proteins that specifically bind host transferrin (Tf) and lactoferrin
(Lf) in the first step of the iron acquisition pathway. Acute- and convalescent-phase antisera from a series of patients with M. catarrhalis pulmonary infections were tested against Tf and Lf receptor proteins purified from the corresponding isolates. After the
purified proteins had been separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and Western blotting, we
observed strong reactivity against Tf-binding protein B (TbpB; also
called OMP1) and Lf-binding protein B (LbpB) but little or no
reactivity against Tf-binding protein A (TbpA) or Lf-binding protein A
(LbpA), using the convalescent-phase antisera. Considerable antigenic
heterogeneity was observed when TbpBs and LbpBs isolated from different
strains were tested with the convalescent-phase antisera. Comparison to
the reactivity against electroblotted total cellular proteins revealed
that the immune response against LbpB and TbpB constitutes a
significant portion of the total detectable immune response to M. catarrhalis proteins. Preparations of affinity-isolated TbpA and
LbpA reacted with convalescent-phase antisera in a solid-phase binding
assay, but blocking with soluble TbpB, soluble LbpB, or extracts from an LbpA
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Analysis of the Immunological Responses to
Transferrin and Lactoferrin Receptor Proteins from
Moraxella catarrhalis
mutant demonstrated that this reactivity was
attributed to contaminants in the TbpA and LbpA preparations. These
studies demonstrate the immunogenicity of M. catarrhalis
TbpB and LbpB in humans and support their potential as vaccine candidates.
*
Corresponding author. Mailing address: Department of
Microbiology and Infectious Diseases, University of Calgary, 3330 Hospital Dr., N.W., Calgary, Alberta, T2N 4N1, Canada. Phone:
403-220-3703. Fax: 403-270-2772. E-mail:
schryver{at}acs.ucalgary.ca.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|